More Amplia Therapeutics Ltd. news Amplia Therapeutics Ltd.ASX: ATX AMP945 and FOLFIRINOX active in model of Pancreatic Cancer May 29, 2023 at 3:03 AM UTC · Issued by Amplia Therapeutics Ltd. As issuedPlain English Amplia Therapeutics Ltd has released a press release. View Attachment